bioAffinity Technologies, Inc.

US$2.71As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BIAFHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (77.79%)
Div yield —
ROE (240.48%)
Diagnostics & Research
Beta (5Y) (1.05)
PE TTM —
TSR TTM (92.61%)
Mkt cap US$3.483M
ROIC (113.36%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.98
9.68%
(60.60%)
Hold 1|0|6|2|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.04
0.04
18.39%
12.00%
13.61%
28.67%
Revenue$M
0.324
0.332
0.346
0.355
7.71%
11.77%
13.28%
10.96%
Peers (US$3.483M)
Cap (US$)
PE
5.055M
—
2.051M
—
3.554M
—
Capital
TTM
5Y
10Y
Leveragex
0.431
0.214
0.191
EBIT/Intx
0.096
0.109
0.127
Own earn%
200.31
(189.88)
(173.03)
Sh yield%
36.11
44.31
44.55
Owners
Insiders/Inst%
2.08
49.64
Short interest%
0.87
SBC / revenue%
3.29
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
11–16
$1 testx
—
Incr. ROIC%
0